$NVAX Income Statement | Understand Stock

$NVAX

$10.02 +$0.62 (6.54%) Live

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Product sales
Licensing, royalties, and other
Grants
Royalties and other
Total revenues
Expenses:
Cost of sales
Research and development
Gain on sale of assets
Selling, general, and administrative
Impairment of assets held for sale
Total expenses

Income (loss) from operations
Other income (expense):
Investment income
Interest expense
Loss on debt extinguishment
Gain on disposition of Novavax CZ assets
Other income, net

Income (loss) before income tax expense
Income tax expense
Net income (loss)
Net income (loss) per share:
Basic (in usd per share)
Diluted (in usd per share)
Weighted average number of common shares outstanding:
Basic (in shares)
Diluted (in shares)

Comments